Work

Glypican‐1‐Targeted Antibody–Drug Conjugate Exhibits Antitumor Effects Against Oral Squamous Cell Carcinoma

Year: 2026

Type: article

Source: Head & Neck

DOI: 10.1002/hed.70514

Authors: Kengo Obata, Satoshi Serada, Yuji Suzuki, Kodai Tuchida, Jun Miyaguchi, Eiji Funajima, Hiroyuki Yamada, Tetsuji Naka

Institution: Iwate Medical University

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science

Awards: Novel antibody-drug conjugate targeting glypican-1 to overcome chemotherapy-refractory pancreatic cancer, G2355433708, G4091215048, Development of a companion diagnostics toward for Glypican-1 targeted antibody-based medicine

OpenAlex ID: W7221776754

FWCI:

Cites: 18

Cited by:

Related to: